Halozyme Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
HALO Nasdaq 2836 halozyme.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Halozyme Therapeutics, Inc.

Unpacking Q2 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks - Oct 1st, 2026 1:17 pm
Halozyme Announces Appointment of Jim Daly to its Board of Directors - Sep 30th, 2026 2:05 pm
Eli Lilly Upgraded, Intel Downgraded: Updated Rankings on Top Blue-Chip Stocks - Sep 28th, 2026 1:13 pm
Why Women-Run Companies Deserve a Place in Your Portfolio - Sep 24th, 2026 10:42 am
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns - Sep 23rd, 2026 8:31 am
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now - Sep 23rd, 2026 6:30 am
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength? - Sep 23rd, 2026 3:30 am
1 Cash-Producing Stock to Target This Week and 2 We Question - Sep 22nd, 2026 3:17 am
Halozyme (HALO) Just Made A $1.3B Bet On Itself - Sep 21st, 2026 8:57 pm
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Sep 21st, 2026 10:03 am
Halozyme Therapeutics (HALO) Proposes $1.05B in Convertibles. Is More Time Worth the Cost? - Sep 20th, 2026 6:27 pm
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033 - Sep 17th, 2026 9:20 pm
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033 - Sep 16th, 2026 2:30 pm
Is Halozyme Therapeutics (HALO) Fully Priced Ahead Of Its September Conference Run? - Sep 16th, 2026 1:09 pm
3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO) - Sep 16th, 2026 10:45 am
Zacks.com featured highlights include Halozyme Therapeutics, Avnet, BILL and Venture Global - Sep 15th, 2026 8:44 am
4 Value Stocks to Buy as Oil Surge Fuels Fed Rate Hike Fears - Sep 15th, 2026 7:36 am
4 Best PEG Value Stocks to Buy Now for Strong Growth & Return - Sep 14th, 2026 1:00 pm
When To Sell Stocks: Why Investors May Want To Walk Away From These IBD 50 Stocks - Sep 11th, 2026 6:00 am
4 High-Growth GARP Stocks With Discounted PEG Ratios for 2026 - Sep 4th, 2026 1:00 pm